PURPOSE: to describe the clinical and laboratorial profile of HELLP syndrome patients admitted at an Obstetric Intensive Care Unit (ICU) and included in a randomized clinical trial to evaluate the efficacy of dexamethasone in this clinical setting. METHODS: the present study is a secondary analysis of a randomized clinical trial design to evaluate the efficacy of dexamethasone in patients with HELLP syndrome. This sample of patients was composed of patients in the puerperium, with the diagnosis of HELLP syndrome (diagnosis made before or after delivery) who were not chronic corticosteroid users and not carriers of any chronic disease which could modify HELLP syndrome's laboratorial parameters. Patients who were too critical or whose condition did not allow them to consent to participate were not included. Data were extracted from the records used in the randomized clinical trial. Age, parity, gestational age at admission and delivery, time of diagnosis (before or after delivery), HELLP syndrome classification (partial or complete), arterial blood pressure, and diuresis at admission were considered for analysis. Among laboratorial findings, hemoglobin, platelet count, liver enzymes, LDH, and serum bilirubin were analyzed. Complications presented by the patients were also analyzed as well as need of blood transfusions and duration of hospitalization. Analysis was made by the Epi-Info 3.3.2 program. RESULTS: one hundred and five patients were analyzed. Age varied from 14 to 49 years (means of 26.7). Regarding parity, 56 patients (53.8%) were primiparas. Analyzing the timing of the diagnosis, 47 patients (45.2%) had the diagnosis before delivery. The mean gestational age in these patients was 32.4 weeks. Hemorrhagic manifestations were observed in 36 patients (34.3%), oliguria was present in 49 patients (46.7%) and criteria for acute renal failure were seen in 21 (20%) of the cases. Hemotransfusions were necessary in 35 (33.3%) patients. Seven patients (6.7%) had pulmonary edema and four patients died, corresponding to 3.8% of the cases. The mean time from diagnosis of HELLP syndrome to discharge or death was 10.3 days, varying from 1 to 33 days. CONCLUSIONS: HELLP syndrome is an ominous diagnosis, which implicates in elevated maternal morbimortality. Among complications, oliguria and hemorrhagic manifestations were the most common findings and hemotransfusions were frequently required. Lethality reached 3.8%.3028086Hypertension in pregnancy (1996) Technical Bulletin, 219. , American College of Obstetricians and Gynecologists, Washington, D.C: The College;Weistein, L., Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy (1982) Am J Obstet Gynecol, 142 (2), pp. 159-167Williams, K.P., Wilson, S., Ethnic variation in the incidence of HELLP syndrome in a hypertensive pregnant population (1999) J Perinat Med, 25 (6), pp. 498-501Magann, E.F., Martin Jr., J.N., Twelve steps to optimal management of HELLP syndrome (1999) Clin Obstet Gynecol, 42 (3), pp. 532-550Suresh, M.S., HELLP syndrome: An anesthesiologist's perspective (1998) Anesthesiol Clin North Am, 16 (2), pp. 332-348Sibai, B.M., The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing? (1990) Am J Obstet Gynecol, 162 (2), pp. 311-316Santos, L.C., Amorim, M.M.R., Katz, L., Albuquerque, C.J.M., Terapia intensiva em obstetrícia. (2004) Rio de Janeiro: Medsi, pp. 63-75Vigil-De Gracia, P., García-Cáceres, E., Dexamethasone in the post-partum treatment of HELLP syndrome (1997) Int J Gynaecol Obstet, 59 (3), pp. 217-221Yalcin, O.T., Sener, T., Hassa, H., Ozalp, S., Okur, A., Effects of postpartum corticosteroids in patients with HELLP syndrome (1998) Int J Gynaecol Obstet, 61 (2), pp. 141-148Katz, L., (2007) Uso da dexametasona em pacientes com síndrome hellp: Ensaio clínico randomizado controlado com placebo [tese], , Campinas: Universidade de Campinas;Mecacci, F., Carignani, L., Cioni, R., Parreti, E., Mignosa, M., Piccioli, A., Time course of recovery and complications of HELLP syndrome with two different treatments: Heparin or dexamethasone (2001) Thromb Res, 102 (2), pp. 99-105Goodwin, A.A., Mercer, B.M., Does maternal race or ethnicity affect the expression of severe preeclampsia? (2005) Am J Obstet Gynecol, 193 (3 PART 2), pp. 973-978Haddad, B., Barton, J.R., Livingston, J.C., Chahine, R., Sibai, B.M., Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome (2000) Am J Obstet Gynecol, 183 (2), pp. 444-448Isler, C.M., Rinehart, B.K., Terrone, D.A., Martin, R.W., Magann, E.F., Martin Jr., J.N., Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome (1999) Am J Obstet Gynecol, 181 (4), pp. 924-928Vallejo Maroto I, Miranda Guisado ML, Stiefel García-Junco P, Pamies Andreu E, Marenco ML, Castro de Gavilan D, et al. Clinical and biological characteristics of a group of 54 pregnant women with HELLP syndrome. Med Clin (Barc). 2004;122(7):259-61Martin Jr, J.N., Rinehart, B.K., May, W.L., Magann, E.F., Terrone, D.A., Blake, P.G., The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification (1999) Am J Obstet Gynecol, 180 (6 PART 1), pp. 1373-1384Romero Arauz, J.F., Lara Gonzalez, A.L., Ramos Leon, J.C., Izquierdo Puente, J.C., Maternal morbidity and mortality in HELLP syndrome (2001) Ginecol Obstet Mex, 69, pp. 189-193Audibert, F., Friedman, S.A., Frangieh, A.Y., Sibai, B.M., Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome (1996) Am J Obstet Gynecol, 175 (2), pp. 460-464Helguera-Martínez, A.M., Tenorio-Marañón, R., Vigil-de Gracia, P.E., García-Cáceres, E., HELLP syndrome. Analysis of 102 cases (1996) Ginecol Obstet Mex, 64, pp. 528-533Sibai, B.M., Taslami, M.M., el-Nazer, A., Amon, E., Mabie, B.C., Ryan, G.M., Maternal-perinatal outcome associated with the syndrome hemolysis, elevated liver enzymes, and low platelets in severe preeclampsiaeclampsia (1986) Am J Obstet Gynecol, 155 (3), pp. 501-509Isler, C.M., Barrilleaux, P.S., Magann, E.F., Bass, J.D., Martin Jr, J.N., A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome (2001) Am J Obstet Gynecol, 184 (7), pp. 1332-1337Fonseca, J.E., Mendez, F., Catano, C., Arias, F., Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: A double-blind, placebo-controlled, randomized clinical trial (2005) Am J Obstet Gynecol, 193 (5), pp. 1591-1598Basavilvazo Rodríguez, A., Pacheco Pérez, C., Lemus Rocha, R., Martínez Pérez, J.M., Martínez Martínez, A., Hernández-Valencia, M., Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care (2003) Ginecol Obstet Mex, 71, pp. 379-386Malvino, E., Muñoz, M., Ceccotti, C., Janello, G., Mc Loughlin, D., Pawlak, A., Maternal morbidity and perinatal mortality in HELLP syndrome. Multicentric studies in intensive care units in Buenos Aires area (2005) Medicina (B Aires), 65 (1), pp. 17-23Sibai, B.M., Hypertension (2002) Obstetrics: Normal and problem pregnancies, pp. 945-1004. , Gabbe SG, Niebyl JR, Simpson JL, editors, 4th ed. New York: Churchill Livingstone;Briggs, R., Chari, R.S., Mercer, B., Sibai, B., Postoperative incision complications after cesarean section in patients with antepartum syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP): Does delayed primary closure make a difference? (1996) Am J Obstet Gynecol, 175 (4 PART 1), pp. 893-896Martin Jr, J.N., Perry Jr, K.G., Blake, P.G., May, W.A., Moore, A., Robinette, L., Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome (1997) Am J Obstet Gynecol, 177 (5), pp. 1011-1017Sibai, B.M., Ramadan, M.K., Usta, I., Salama, M., Mercer, B.M., Friedman, S.A., Maternal-morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) (1993) Am J Obstet Gynecol, 169 (4), pp. 1000-1006Gul, A., Aslan, H., Cebeci, A., Polat, I., Ulusoy, S., Ceylan, Y., Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure (2004) Ren Fail, 26 (5), pp. 557-562Martínez de Ita, A.L., García Cáceres, E., Helguera Martínez, A.M., Cejudo Carranza, E., Acute renal insufficiency in HELLP syndrome (1998) Ginecol Obstet Mex, 66, pp. 462-468